These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33542213)

  • 1. The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
    Ho NPY; Leung CON; Wong TL; Lau EYT; Lei MML; Mok EHK; Leung HW; Tong M; Ng IOL; Yun JP; Ma S; Lee TKW
    Cell Death Dis; 2021 Feb; 12(2):148. PubMed ID: 33542213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
    Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
    Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE2T promotes β-catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK-dependent activation.
    Lioulia E; Mokos P; Panteris E; Dafou D
    Mol Oncol; 2022 Apr; 16(8):1694-1713. PubMed ID: 34614271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN; Chen DM; Chen XR; Gu YR; Liao CH; Xiao LX; Wang JL; Lin BL; Huang YH; Lian YF
    Cell Oncol (Dordr); 2024 Oct; 47(5):1897-1910. PubMed ID: 39080215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway.
    Wang Y; Gao G; Wei X; Zhang Y; Yu J
    Drug Des Devel Ther; 2023; 17():1357-1369. PubMed ID: 37181827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination.
    Yu Z; Jiang X; Qin L; Deng H; Wang J; Ren W; Li H; Zhao L; Liu H; Yan H; Shi W; Wang Q; Luo C; Long B; Zhou H; Sun H; Jiao Z
    Oncogene; 2021 Feb; 40(5):1027-1042. PubMed ID: 33323973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
    Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
    Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
    Ren X; Li A; Ying E; Fang J; Li M; Yu J
    Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
    Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
    Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
    Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
    BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
    Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
    Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling.
    Fan Z; Duan J; Wang L; Xiao S; Li L; Yan X; Yao W; Wu L; Zhang S; Zhang Y; Li Y; Zhu X; Hu Y; Zhang D; Jiao S; Xu X
    Cancer Lett; 2019 May; 450():132-143. PubMed ID: 30849480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein promotes the stem-like properties of OV6
    Wang C; Wang MD; Cheng P; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Wu MC; Zhou WP
    Cell Death Dis; 2017 Jan; 8(1):e2560. PubMed ID: 28102846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.